Introduction {#s1}
============

The σ subunit of bacterial RNA polymerase (RNAP) is an essential initiation factor that specifies the recognition of promoter sequences in the context of the RNAP holoenzyme ([@bib9]). All bacteria contain a primary σ factor that directs transcription from the major class of bacterial promoters; in addition, most bacteria contain multiple alternative σ factors that direct transcription from specialized promoters in response to stress or alterations in growth state ([@bib14]; [@bib36]; [@bib15]). Among the best-studied primary σ factors is *Escherichia coli* σ^70^, which recognizes promoters that are defined by two conserved hexameric DNA sequence elements termed the −10 and the −35 elements (consensus sequences: TATAAT and TTGACA, respectively). Members of the σ^70^ family share a conserved 4-domain architecture, with domain 2 contacting the −10 element and domain 4 contacting the −35 element ([@bib13]; [@bib38]; [@bib9]; [@bib37]). *E. coli* also has six alternative σ factors, five of which are members of the σ^70^ family and recognize similarly positioned promoter elements using the counterparts of σ^70^ domains 2 and 4. Most alternative σ factors exhibit highly restricted promoter specificity ([@bib21]; [@bib46]). Thus, genes that are responsive to disparate physiological inputs often carry two or more promoters that are recognized by distinct σ factors ([@bib54]; [@bib10]; [@bib6]).

Although σ factors were historically identified as promoter specificity factors, it has become clear that their roles are not limited to the initiation phase of transcription. In particular, multiple studies have shown that the release of σ from the transcription complex is not required for entry into the elongation phase of transcription (reviewed in [@bib27]; [@bib43]). Furthermore, the functional properties of a transcription elongation complex (TEC) containing σ differ from the properties of a TEC that does not contain σ. For example, TEC-associated σ^70^ can induce transcription pausing by engaging promoter −10-like sequence elements within transcribed regions ([@bib47]; [@bib3]; [@bib33]; [@bib16]; [@bib8]; [@bib43]), a phenomenon that was first uncovered in the context of the bacteriophage λ late gene promoter (reviewed in [@bib48]; [@bib43]). This pausing occurs due to an interaction between the −10-like element and domain 2 of TEC-associated σ^70^ (the same domain of σ^70^ that binds the promoter −10 element during transcription initiation). In addition, the presence or absence of σ can alter the accessibility of the TEC to elongation factors, including the λ Q protein and RfaH ([@bib48]; [@bib35], [@bib34]; [@bib50]), and can influence the ability of RNAP to reinitiate transcription at certain promoters ([@bib1]).

Initial-transcribed-region −10-like elements, such as those associated with the λ late promoters and the late promoters of other lambdoid phages, induce early elongation pausing because they are recognized by TECs that have not yet released the σ^70^ that was used during initiation ([@bib25]; [@bib30]; [@bib33]; [@bib19]). In prior work, we showed that such promoter-proximal σ^70^-dependent pause elements also function to inhibit σ^70^ loss during the earliest stages of elongation, increasing the σ^70^ content of downstream TECs ([@bib8]). This effect can be detected using a template that carries a second pause element positioned downstream of a promoter-proximal pause element; specifically, the presence of the promoter-proximal pause element facilitates the retention of σ^70^ in the TEC and thus substantially enhances the extent of pausing induced by the downstream pause element both in vitro and in vivo ([@bib8]).

Although promoter −10-like elements that induce transcription pausing can be recognized by a σ^70^ subunit that has been retained in the TEC after promoter escape, in vitro studies have established that transcribed region −10-like elements can also be recognized by a σ^70^ subunit that was not present during initiation, but rather joined the TEC by loading *in trans* during elongation. Thus, it has been shown that the efficiency of pausing induced by transcribed region −10-like elements can be increased in vitro by increasing the concentration of free σ^70^ in the transcription reactions ([@bib29]; [@bib50]; [@bib8]; [@bib49]). A key question that emerges from these in vitro findings is whether or not cellular conditions permit σ^70^ to gain access to the TEC through this *'trans*-acting pathway' in vivo. Here we address this question by employing an assay that enables us to measure the extent of TEC pausing induced by a −10-like element within a transcribed region in vivo. We find that the extent of pausing induced by a transcribed-region −10-like element is sensitive to the intracellular concentration of σ^70^, indicating that σ^70^ can gain access to the TEC *in trans*. We further establish that σ^70^ can gain access to the TEC *in trans* and engage −10-like elements within transcribed regions that are expressed under the control of either a σ^70^-dependent promoter or a promoter that is recognized by an alternative σ factor. In addition, we show that the extent of TEC pausing mediated by σ^70^ *trans* loading varies as a function of growth-phase. Our findings imply that distinct σ factors can control initiation and elongation on the same transcription unit in vivo, and that the functional consequences of σ^70^ *trans* loading vary as a function of growth state.

Results {#s2}
=======

Detection of σ^70^ *trans* loading on a σ^70^-dependent transcription unit in vivo {#s2-1}
----------------------------------------------------------------------------------

To determine whether or not σ^70^ can bind *in trans* to the TEC in vivo, we took advantage of the fact that TEC-associated σ^70^ can induce transcription pausing by engaging transcribed-region −10-like elements. We therefore sought to determine whether or not the efficiency of pausing induced by a transcribed-region −10-like element was sensitive to the concentration of σ^70^ present in vivo. To do this, we introduced into *E. coli* cells a plasmid carrying a σ^70^-dependent promoter, λP~R′~, fused to a transcribed region containing a −10-like element that has the potential to induce σ^70^-dependent pausing at a nascent RNA length of ∼35 nt ([@bib8]) ([Figure 1A](#fig1){ref-type="fig"}, top); the transcription unit also contains an intrinsic terminator element (positioned to terminate transcription after the synthesis of an ∼116 nt transcript). Pausing induced by the −10-like element on this template in vitro is sensitive to the concentration of free σ^70^ in the transcription reactions ([@bib8]); furthermore, because the template lacks a promoter-proximal −10-like element, engagement of the pause element by σ^70^ that is retained during the transition from initiation to elongation contributes minimally to the observed pausing ([@bib8]).10.7554/eLife.10514.003Figure 1.σ^70^ *trans* loading on a σ^70^-dependent transcription unit in vivo (MG1655).(**A**) *Top:* schematic of DNA template carrying λP~R\'~, transcribed-region consensus extended --10 element (wild-type or mutant) and terminator (see 'Materials and methods' for the λP~R′~ promoter sequence). Transcribed-region sequences that are complementary to the LNA probe are underlined (grey bar) and the positions corresponding to pause sites are indicated. *middle* Analysis of RNA transcripts in vivo by LNA probe-hybridization. RNA was isolated from MG1655 cells harvested at an OD~600~ of 0.8--1.0 (see 'Materials and methods'). Pausing is quantified by dividing the signal in the ∼35-nt pause RNA band by the sum of this signal and the signal in the terminated (full-length) band; this ratio is expressed as a percentage (relative abundance). Mean and SEM of six independent measurements are shown. Asterisks (\*) designate values that were too low (\<approximately threefold above background) for accurate quantification. M, 10-nt RNA ladder. *bottom* Analysis of σ^70^ levels by Western blot. Amount of soluble σ^70^ is normalized to the amount in cells carrying the experimental template (wt) and a vector that does not direct σ^70^ over-production. Mean and SEM of three independent measurements are shown. (**B**) *Top*: schematic of DNA template carrying λP~R′~, initial-transcribed-region σ^70^-dependent pause element, transcribed-region consensus −10 element and terminator. *middle* Analysis of RNA transcripts in vivo by locked-nucleic-acid (LNA) probe-hybridization, as in panel **A**. *bottom* Analysis of σ^70^ levels by Western blot.**DOI:** [http://dx.doi.org/10.7554/eLife.10514.003](10.7554/eLife.10514.003)

We tested whether or not the efficiency of pausing at a nascent RNA length of ∼35 nt on this template was sensitive to the concentration of σ^70^ present in vivo by introducing into the cells a second plasmid that did or did not direct the production of excess σ^70^. To detect nascent RNAs associated with paused TECs (pause RNAs) and full-length terminated transcripts produced from this template, we isolated total RNA and used Northern blotting with a locked-nucleic-acid (LNA) probe, as described previously ([@bib8]). We quantified the extent of pausing by dividing the signal associated with a pause RNA by the sum of this signal and the signal associated with the full-length terminated transcript (hereafter termed relative abundance). We found that the relative abundance of a ∼35-nt pause RNA (see [@bib8]) increased ∼fivefold when σ^70^ was overproduced by a factor of ∼7, compared to that observed in cells containing chromosomally encoded σ^70^ only ([Figure 1A](#fig1){ref-type="fig"}). Furthermore, the ∼35-nt pause RNA was barely detected with or without excess σ^70^ using a control template carrying base-pair substitutions that disrupt sequence-specific recognition of the transcribed-region −10-like element by σ^70^ region 2 ([@bib8]) ([Figure 1A](#fig1){ref-type="fig"}). We conclude that pausing of the TEC under the control of a −10-like element within a transcribed region is sensitive to the intracellular concentration of σ^70^, suggesting that σ^70^ can access the TEC *in trans*, in vivo.

Next, we investigated whether or not σ^70^ *trans* loading could augment the effect of a promoter-proximal pause element on the σ^70^ content of downstream TECs. To do this, we used LNA probe-hybridization to detect transcripts produced from the template shown in [Figure 1B](#fig1){ref-type="fig"}. This λP~R′~ template bears the same −10-like element as the template shown in [Figure 1A](#fig1){ref-type="fig"}, but in addition carries a promoter-proximal −10-like element (positioned between +1 and +6) that induces σ^70^-dependent pausing at a nascent RNA length of ∼16 nt. Consistent with previous findings ([@bib8]), the presence of the promoter-proximal −10-like element resulted in a substantial increase (∼ninefold) in the relative abundance of the ∼35-nt pause species (compare [Figure 1A,B](#fig1){ref-type="fig"}). Nonetheless, when σ^70^ was overproduced, the relative abundance of the ∼35-nt pause species increased further (∼1.5 fold; [Figure 1B](#fig1){ref-type="fig"}, middle and bottom panels), indicating that the effect of the promoter-proximal −10-like element on the σ^70^ content of downstream TECs is not saturating.

Detection of σ^70^ *trans* loading on a transcription unit expressed under the control of an alternative sigma factor in vitro and in vivo {#s2-2}
------------------------------------------------------------------------------------------------------------------------------------------

We next sought to determine whether or not free σ^70^ can bind to TECs on a transcription unit controlled by an alternative σ factor. To address this possibility we generated a new template that carried a promoter recognized by RNAP holoenzyme carrying σ^28^, an alternative σ factor that controls the expression of genes involved in flagellar synthesis ([@bib5]; [@bib20]). This σ^28^ dependent promoter (P*tar*) was fused to the same transcribed region sequences that are present on the λP~R′~ template shown in [Figure 1A](#fig1){ref-type="fig"} starting at position +6 (including the −10-like element; [Figure 2A](#fig2){ref-type="fig"}). We first performed in vitro transcription experiments to determine whether or not σ^70^ could access the TEC and induce pausing on this template. We formed open complexes on P*tar* using RNAP holoenzyme containing σ^28^ and then allowed a single round of transcription to occur in the absence or presence of excess σ^70^. We monitored the RNA content of each reaction at three time points after the initiation of transcription. Addition of σ^70^ to the transcription reactions resulted in the appearance of a cluster of RNAs ∼35-nt in length ([Figure 2](#fig2){ref-type="fig"}, compare lanes 4--6 with lanes 1--3). These RNAs were not observed when reactions were performed using a control template carrying disruptive base-pair substitutions within the transcribed-region −10-like element ([Figure 2B](#fig2){ref-type="fig"}, lanes 7--12). A set of reactions performed in the presence of σ^70^ but in the absence of σ^28^ confirmed that appearance of the cluster of ∼35-nt RNAs is strictly dependent on transcription that initiates from P*tar* under the control of σ^28^ ([Figure 2B](#fig2){ref-type="fig"}, lanes 13--15). In addition, the distribution of RNA species within this cluster closely resembles that within a similar cluster produced when reactions were performed using the λP~R′~ template ([Figure 1A](#fig1){ref-type="fig"}) and RNAP holoenzyme containing σ^70^ ([Figure 2B](#fig2){ref-type="fig"}, lanes 16--18). We conclude that the ∼35-nt RNAs are pause RNAs that arise due to the ability of σ^70^ to bind TECs generated via transcription initiating at P*tar* under the control of σ^28^. These findings therefore indicate that free σ^70^ can bind to TECs on a σ^28^-controlled transcription unit in vitro.10.7554/eLife.10514.004Figure 2.σ^70^ *trans* loading on a σ^28^-dependent transcription unit in vitro.(**A**). Schematic of DNA template carrying P*tar*, transcribed-region consensus −10 element (wild-type or mutant) and terminator. Template positions corresponding to pause sites are indicated. Note that the pause sites and terminated transcripts emanating from the P*tar* promoter are located one base closer to the transcription start site (+1) than on the λP~R′~ template ([Figure 1A](#fig1){ref-type="fig"}). (See 'Materials and methods' for the P*tar* promoter sequence.) (**B**). Analysis of RNA transcripts in vitro. Single-round in vitro transcription reactions were performed with reconstituted RNA polymerase (RNAP) holoenzyme containing σ^28^ (lanes 1--12), RNAP core enzyme (lanes 13--15) or reconstituted RNAP holoenzyme containing σ^70^ (lanes 16--18) and three different templates: P*tar* with a wild-type (wt) transcribed-region −10 element (lanes 1--6 & 13--15) or a mutated (mut) transcribed-region −10 element (lanes 7--12) and λP~R′~ with a wild-type transcribed-region −10 element (lanes 16--18). The reactions were performed as a time course with samples taken at 1, 6 and 18 min after transcription was initiated; these reactions were performed in the absence of transcript cleavage factors GreA and GreB, resulting in a characteristic pattern of long-lived pause species ([@bib8]). Where indicated, excess σ^70^ (1 μM) was added with the 'start mix' after open complex formation. RNAs associated with paused transcription elongation complexes (TECs) (pause) and terminated transcripts (full length) are labeled. The asterisk (\*) indicates a shorter terminated transcript that is the result of transcription initiating under the control of the transcribed-region −10 element when the σ^70^-containing holoenzyme is present in the reaction.**DOI:** [http://dx.doi.org/10.7554/eLife.10514.004](10.7554/eLife.10514.004)

We then sought to determine whether or not σ^70^ can bind to TECs on a σ^28^-controlled transcription unit in vivo. For this experiment we introduced into cells three compatible plasmids. The first plasmid carried either the wild-type P*tar* template or a mutant P*tar* template with base-pair substitutions that disrupt sequence-specific recognition of the transcribed-region −10-like element by σ^70^. The second plasmid did or did not direct the production of excess σ^70^ and the third plasmid did or did not direct the production of excess σ^28^. We isolated total RNA and soluble protein from cells and used LNA probe-hybridization to detect transcripts emanating from the P*tar* promoter ([Figure 3A](#fig3){ref-type="fig"}, top) and Western blotting to assess the concentrations of σ^70^ ([Figure 3A](#fig3){ref-type="fig"}, middle) and σ^28^ ([Figure 3A](#fig3){ref-type="fig"}, bottom). We found that transcripts emanating from P*tar* were detected only in cells carrying the plasmid that directed the synthesis of excess σ^28^ ([Figure 3A](#fig3){ref-type="fig"}, compare lanes 2--5 with lane 6). Furthermore, in the presence of excess σ^28^ but in the absence of excess σ^70^, we detected a small amount of an RNA species that migrated between the 30-nt and 40-nt RNA markers ([Figure 3A](#fig3){ref-type="fig"}, lane 2). This RNA species was similar in size to the ∼35-nt pause RNA detected by LNA probe-hybridization with the λP~R′~ template in vivo ([Figure 1A](#fig1){ref-type="fig"}) and to the cluster of ∼35-nt pause RNAs produced from the P*tar* template in vitro in the presence of excess σ^70^ ([Figure 2B](#fig2){ref-type="fig"}, lanes 4--6). We found that the relative abundance of this ∼35-nt RNA was increased ∼sevenfold when σ^70^ was overproduced by a factor of ∼3 ([Figure 3A](#fig3){ref-type="fig"}, compare lanes 2 and 3). In addition, the ∼35-nt RNA was not detected in cells containing the mutant P*tar* template carrying base-pair substitutions in the transcribed-region −10-like element ([Figure 3A](#fig3){ref-type="fig"}, lanes 4 and 5).10.7554/eLife.10514.005Figure 3.σ^70^ *trans* loading on a σ^28^-dependent transcription unit in vivo.(**A**). *top* Detection of RNA transcripts in vivo from the templates shown in [Figure 2A](#fig2){ref-type="fig"} by LNA probe-hybridization. Transcribed-region sequences that are complementary to the LNA probe are as in [Figure 1A](#fig1){ref-type="fig"}. RNA was isolated from MG1655 cells harvested at an OD~600~ of 0.8--1.0. Pausing is quantified by dividing the signal in the ∼35-nt pause RNA band by the sum of this signal and the signal in the terminated (full-length) band. Mean and SEM of three independent measurements are shown. Asterisks (\*) designate values that were too low for accurate quantification. M, 10-nt RNA ladder. *middle* Analysis of σ^70^ levels by Western blot. Amount of soluble σ^70^ is normalized to the amount in cells carrying the experimental template (wt) and a vector that does not direct σ^70^ over-production. Mean and SEM of three independent measurements are shown. *bottom* Analysis of σ^28^ levels by Western blot. (**B**). Analysis of RNAP-associated transcripts produced from the wild-type P*tar* template. RNA was isolated from the lysate fraction (lys) or the immunoprecipitated fraction (IP) of SG110 cells (OD~600~ ∼0.5) and analyzed by LNA probe-hybridization. The cells contained a vector directing the synthesis of σ^28^, as well as a vector that did or did not direct σ^70^ overproduction.**DOI:** [http://dx.doi.org/10.7554/eLife.10514.005](10.7554/eLife.10514.005)

Next, we sought to determine whether or not the ∼35-nt RNA species produced under the control of the P*tar* promoter was RNAP-associated, as would be expected for a pause RNA. To carry out this experiment, we used a strain carrying a chromosomal *rpoC-3xFLAG* gene, encoding the RNAP β′ subunit with a C-terminal 3xFLAG tag, which enables us to isolate RNAP-associated transcripts by immunoprecipitating RNAP with an antibody against FLAG. We introduced into this strain the plasmid carrying the wild-type P*tar* template, the plasmid directing the production of excess σ^70^ or the corresponding empty vector, and the plasmid directing the production of excess σ^28^. We isolated RNA from cell lysates ([Figure 3B](#fig3){ref-type="fig"}, lys) or from 3×FLAG-tagged TECs immunoprecipitated with an antibody against FLAG ([Figure 3B](#fig3){ref-type="fig"}, IP) and used LNA probe-hybridization to detect transcripts emanating from the P*tar* promoter. The results indicate that a major fraction of the ∼35-nt RNA species, but not the full-length terminated transcript, was immunoprecipitated with an antibody against FLAG whether the cells lacked or contained plasmid encoded overproduced σ^70^ ([Figure 3B](#fig3){ref-type="fig"}). Thus, we conclude that a major fraction of the ∼35-nt RNA species, but not the full-length terminated transcript, is RNAP-associated.

Taken together, the results of [Figure 3](#fig3){ref-type="fig"} establish that the appearance of the ∼35-nt RNA depends both on the presence of σ^28^ and on an intact −10-like element, that the relative abundance of the ∼35-nt RNA is increased upon overproduction of σ^70^, and that the ∼35-nt RNA is RNAP-associated. We therefore conclude that the ∼35-nt RNA produced from the P*tar* template in vivo represents a pause RNA that arises due to the ability of σ^70^ to bind TECs generated under the control of σ^28^. Furthermore, our ability to detect σ^70^-dependent pause species produced under the control of a promoter that is recognized by an alternative σ factor enables us unambiguously to identify pausing that is mediated by *trans*-loaded σ^70^. Thus, our findings establish that σ^70^ can access the TEC *in trans*, in vivo.

Effect of growth phase on the extent of σ^70^-dependent pausing due to *trans* loaded σ^70^ {#s2-3}
-------------------------------------------------------------------------------------------

Although experiments using the P*tar* template revealed that σ^70^ *trans* loading is detectable even in the absence of σ^70^ overproduction, we found that during the exponential phase of growth the extent of pausing due to chromosomally encoded *trans*-loaded σ^70^ appeared to be low ([Figures 3A](#fig3){ref-type="fig"} and [4A](#fig4){ref-type="fig"}; the relative abundance of the ∼35-nt RNA was \<5%). However, when we harvested RNA from stationary phase cells containing the P*tar* template, we found that the relative abundance of the ∼35-nt RNA was ∼50% ([Figure 4A](#fig4){ref-type="fig"}, lane 3), which was reduced to ∼10% when the transcribed-region −10-like element was mutated ([Figure 4A](#fig4){ref-type="fig"}, lane 5). Furthermore, like those detected during exponential phase, the ∼35-nt RNAs detected from the P*tar* template during stationary phase were RNAP-associated ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Thus, the ∼35-nt RNAs detected during both exponential phase and stationary phase exhibit hallmarks of a σ^70^-dependent pause species (stable association with RNAP and sensitivity to mutations in the transcribed region −10-like element). We conclude that the relative abundance of pause RNAs that arise due to σ^70^ *trans* loading varies with growth-phase.10.7554/eLife.10514.006Figure 4.Growth phase dependent σ^70^ *trans* loading on a σ^28^-dependent transcription unit in vivo.(**A**). Detection of RNA transcripts in vivo from the templates shown in [Figure 2A](#fig2){ref-type="fig"} by LNA probe-hybridization. Transcribed-region sequences that are complementary to the LNA probe are as in [Figure 1A](#fig1){ref-type="fig"}. RNA was isolated from SG110 cells harvested at an OD~600~ of ∼0.5 (log) or ∼2.5 (sta). Pausing is quantified by dividing the signal in the ∼35-nt pause RNA band by the sum of this signal and the signal in the terminated (full-length) band. Mean and SEM of six independent measurements are shown. Asterisks (\*) designate values that were too low for accurate quantification. M, 10-nt RNA ladder. (**B**). *top* Detection of RNA transcripts derived from the wt template in vivo after treatment with rifampicin. *bottom* Percent of transcript remaining relative to T = 0 at indicated time points after addition of rifampicin. Mean and SEM of ten (log, 1 m), eight (sta, 1 m), or six (log and sta, 3 m) independent measurements are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.10514.006](10.7554/eLife.10514.006)10.7554/eLife.10514.007Figure 4---figure supplement 1.(**A**). Analysis of RNAP-associated transcripts produced from the wild-type P*tar* template.RNA was isolated from the lysate fraction (lys) or the immunoprecipitated fraction (IP) of SG110 cells (OD~600~ ∼2.5) and analyzed by LNA probe-hybridization. The cells contained a vector directing the synthesis of σ^28^. (**B**). Analysis of σ^70^ levels by Western blot. Relative quantification of σ^70^ *(top)* is normalized to the abundance of rpoA (α) in each sample *(bottom)*. Mean and SEM of six independent measurements are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.10514.007](10.7554/eLife.10514.007)

To investigate the basis for the growth phase-dependent change in the abundance of the pause RNAs that arise due to σ^70^ *trans* loading, we first performed Western blot analysis to compare the amounts of σ^70^ in exponential and stationary phase cells. The results indicated that the cell extracts prepared from exponential and stationary phase cultures contained comparable amounts of σ^70^ ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). We conclude that the growth phase-dependent increase in the abundance of the ∼35-nt pause RNAs is not a consequence of an increase in the total cellular concentration of σ^70^. (We note that these data do not exclude the possibility that growth phase-dependent changes in the amount of free σ^70^ available to bind the TEC contribute to changes in the abundance of the pause RNAs that arise due to σ^70^ *trans* loading.)

We next used the RNAP inhibitor rifampicin to analyze the half-life of pause RNAs that arise due to σ^70^ *trans* loading during exponential phase or stationary phase. To do this, we isolated RNA from cells either just before or 1 and 3 min after rifampicin treatment and used LNA-probe hybridization to measure the decay of the ∼35-nt RNAs and full-length transcripts. We found that the half-life of the ∼35-nt pause RNA was greater in stationary phase than in exponential phase ([Figure 4B](#fig4){ref-type="fig"}). In addition, the full-length terminated transcript was at least as stable in stationary phase as in exponential phase ([Figure 4B](#fig4){ref-type="fig"}), excluding the possibility that the increase in the relative abundance of the pause RNA might simply reflect a destabilization of the full-length transcript in stationary phase. Thus, our findings indicate that the extent of pausing on the P*tar* template due to *trans*-loaded σ^70^ varies with growth phase, at least in part, due to an increase in the half-life of the pause.

Discussion {#s3}
==========

Here we show that the primary σ factor of *E. coli* can act as a classical elongation factor and engage the TEC *in trans*, in vivo, inducing transcription pausing by binding transcribed-region promoter-like elements ([Figures 1, 3 and 4](#fig1 fig3 fig4){ref-type="fig"}). Furthermore, we find that the extent of pausing due to *trans*-loaded σ^70^ varies with growth phase, becoming most prominent during the stationary phase of growth ([Figure 4](#fig4){ref-type="fig"}). We demonstrate that σ^70^ *trans* loading can occur in vivo regardless of whether the TEC was generated through initiation at a σ^70^-dependent promoter ([Figure 1](#fig1){ref-type="fig"}) or a promoter that is recognized by an alternative σ factor ([Figures 3, 4](#fig3 fig4){ref-type="fig"}). Our findings indicate that at least two distinct σ factors can influence the functional properties of a transcription complex during the transcription cycle in vivo: one during initiation and one (or more) during elongation.

Dual pathways for σ^70^ to associate with the TEC in vivo {#s3-1}
---------------------------------------------------------

The results presented here, coupled with prior work ([@bib52]; [@bib47]; [@bib1]; [@bib30]; [@bib3]; [@bib33]; [@bib55]; [@bib19]; [@bib44]; [@bib45]; [@bib28]; [@bib8]) define two pathways whereby σ^70^ can access the TEC in vivo, a pathway that operates in *cis* and a pathway that operates in *trans* ([Figure 5](#fig5){ref-type="fig"}). The *cis*-acting pathway depends on retention in the TEC of the σ^70^ that was used during initiation, with the extent of σ^70^ retention being modulated by the sequence of the initial transcribed region ([Figure 5A](#fig5){ref-type="fig"}) ([@bib8]). Thus, the *cis*-acting (retention) pathway is necessarily restricted to transcription units controlled by σ^70^-dependent promoters. In contrast, the *trans*-acting pathway identified in this study, which can be functionally defined by its sensitivity to the intracellular concentration of σ^70^, is potentially operative on all transcription units ([Figure 5B](#fig5){ref-type="fig"}). Moreover, the two pathways can function in concert. Thus, we found that σ^70^ *trans* loading can increase the σ^70^ content of TECs generated under the control of a σ^70^-dependent promoter even in the presence of an initial-transcribed-region σ^70^-dependent pause element that augments σ^70^ retention.10.7554/eLife.10514.008Figure 5.Dual pathways for σ^70^ to associate with the TEC in vivo.(**A**). *Cis*-acting pathway ([@bib8]). The retention in the TEC of the σ^70^ that was used during initiation enables pausing at transcribed-region −10-like elements on transcription units that are expressed under the control of σ^70^-dependent promoters. Presence of an initial-transcribed-region σ^70^-dependent −10-like element increases the σ^70^ content of downstream TECs and increases the efficiency of pausing at a second σ^70^-dependent pause element further downstream. Promoter, grey rectangle; σ^70^-dependent pause elements, black rectangles; RNA, wavy red line. (**B**). *Trans*-acting pathway. Binding of σ^70^ to TECs that have lost the σ factor used during initiation (here, σ^28^) increases the efficiency of pausing at a transcribed-region σ^70^-dependent pause element. Promoter, blue rectangle; σ^70^-dependent pause element, black rectangle; RNA, wavy red line.**DOI:** [http://dx.doi.org/10.7554/eLife.10514.008](10.7554/eLife.10514.008)

The use of a transcription unit expressed under the control of an alternative σ factor enabled us to analyze the *trans*-acting pathway independent of the *cis*-acting pathway. We found that the effects of *trans*-loaded σ^70^ on pausing varied with growth phase. In particular, pausing mediated by chromosomally encoded *trans*-loaded σ^70^ was detectable during the exponential phase of growth and this pausing became more prominent during stationary phase. Our experiments revealed that this increase in the relative abundance of the pause species during stationary phase was explained at least in part by an increase in pause half-life in stationary phase cells as compared to exponentially growing cells. We speculate that this increase in pause half-life might be due to a drop in the intracellular NTP concentrations as nutrients are depleted and the cells enter stationary phase ([@bib4]).

It is intriguing to consider our findings in light of a prior report of growth-phase dependent changes in the ability of purified RNAP holoenzyme to retain σ^70^ during transcription elongation as assayed in vitro ([@bib1]). In particular, the authors of this study found that RNAP holoenzyme purified from stationary phase cells produced a substantially higher fraction of σ^70^-containing TECs than did RNAP holoenzyme purified from exponentially growing cells, possibly suggesting that the stationary phase RNAP core enzyme binds σ^70^ more tightly.

We note that the effect of growth phase on the relative abundance of pause RNAs may not be limited to σ^70^--dependent pausing. In fact, our experiments revealed a potential pause species that was detectable above background in stationary phase cells even when the transcribed-region −10-like element was mutated ([Figure 4A](#fig4){ref-type="fig"}, lane 5). We suggest that this RNA arises due to the presence of an overlapping consensus pause element that is recognized by the core RNAP (G~--10~Y~--1~G~+1~; see [Figure 2A](#fig2){ref-type="fig"}) ([@bib17]; [@bib23]; [@bib53]) and is not disrupted by the mutations in the −10-like element.

σ cross regulation {#s3-2}
------------------

Two or more different σ factors often control the expression of a given gene by directing initiation from distinct upstream promoters ([@bib54]; [@bib10]; [@bib6]). Our findings illustrate another mechanism whereby the combined input of multiple σ factors can modulate gene expression. Specifically, we show that distinct σ factors can direct initiation and modulate elongation on the same transcription unit. Such 'σ cross regulation' might enable the cell to integrate signals transmitted via σ^70^ and an alternative σ factor to modulate gene expression within a single transcription unit under the control of a non σ^70^--dependent promoter. In principle there are several ways that σ^70^ *trans* loading might modulate gene expression. First, as shown here, σ^70^ *trans* loading can cause the TEC to pause, which is expected to influence transcription output directly in a manner that depends on pause half-life (and, as suggested by our results shown in [Figure 4](#fig4){ref-type="fig"}, may become particularly relevant in stationary phase). σ^70^--dependent pausing might also influence gene expression indirectly, by facilitating engagement of regulatory factors, influencing formation of RNA secondary structures, or influencing translation ([@bib48]; [@bib56]; [@bib22]; [@bib40]; [@bib24]; [@bib42]; [@bib23]; [@bib32]; [@bib2]). Second, σ^70^ *trans* loading might impede the accessibility of the TEC to other elongation factors such as NusG or RfaH, which share the same primary binding site on RNAP ([@bib50]; [@bib28]).

Future work will be required to investigate the extent to which σ^70^ *trans* loading contributes to gene expression through these or other mechanisms. In this regard, the application of sequencing-based methodologies such as native elongating transcript sequencing (NET-seq) ([@bib7]; [@bib23]; [@bib53]) and chromatin immunoprecipitation sequencing (ChIP-seq) ([@bib31]) should enable the identification of transcription units that manifest growth phase-dependent pausing attributable to *trans* loaded σ^70^. Nevertheless, our findings add to a growing body of evidence that the functions of σ are not limited to the initiation phase of transcription. Furthermore, they establish a mechanism whereby the primary σ factor can extend its reach by exerting direct effects on the composition of the entire transcriptome, not just that portion that is produced under the control of σ^70^-dependent promoters.

Materials and methods {#s4}
=====================

Strains {#s4-1}
-------

All experiments were performed in *E. coli* strain MG1655 or SG110 ([@bib53]) in which the chromosomal *rpoC* gene is fused to a 3xFLAG epitope tag-encoding sequence.

Plasmids {#s4-2}
--------

Plasmids used in this study are listed in [Table 1](#tbl1){ref-type="table"}. Promoter sequences are as follows. λP~R′~ : TTGACTtattgaataaaattgggTAAATTtgactcA and P*tar*: TAAAGTTTcccccctccttGCCGATAAcgagatcA, where the −10 and −35 elements and the +1 nucleotide are capitalized.10.7554/eLife.10514.009Table 1.Plasmids**DOI:** [http://dx.doi.org/10.7554/eLife.10514.009](10.7554/eLife.10514.009)PlasmidDescriptionSourcepLHN12-HispT7-His~6~-*rpoD*([@bib41])pET15b-His-fliApT7-His~6~-*fliA*This workpFW11tet-P~R′~\_+19λP~R′~ promoter and native σ^70^-dependent pause element with a second σ^70^-dependent pause element located 19 bp downstream of the +1 transcription start site. The t~R′~ intrinsic terminator is positioned to terminate transcription ∼116 bp downstream of +1.([@bib8])pFW11tet-mutP~R′~\_+19Same as pFW11tet-P~R′~\_+19 but with A+2 G/T+6 G mutations in the native σ^70^-dependent pause element.([@bib8])pFW11tet-Ptar\_+19 (pNUN175)Same as pFW11tet-P~R′~\_+19 except that the promoter (up to and including +1) has been replaced with the σ^28^-dependent P*tar* promoter.This workpFW11tet-Ptar_mut+19 (pNUN176)Same as pFW11tet-Ptar\_+19 but with mutations in the pause element.This workpBR-*fliA*pSG585-*fliA*This workpSG585colE1 origin plasmid with lacUV5 upstream of multiple cloning siteThis workpNUN191pCDFlacMUT3-rpoDThis workpCDFlacMUT3pCDFlac with attenuated −35 element (AATACA)This workpCDFlacderivative of pCDF-1b into which the lacUV5 promoter has been inserted([@bib26])

Cell growth {#s4-3}
-----------

Single colonies of *E. coli* strains bearing the appropriate plasmids were used to inoculate individual 5 ml aliquots of LB broth (Miller) (10 g tryptone, 5 g yeast extract, 10 g NaCl per liter) (EMD-Millipore, Billerica, MA) containing antibiotics (spectinomyin \[50 μg/ml\] and streptomycin \[25 μg/ml\] were used together to maintain vectors bearing the *aadA1 \[Sm*^*R*^*\]* allele; carbenicillin \[100 μg/ml\]; chloramphenicol \[25 μg/ml\]) in 18 × 150 mm glass culture tubes which were incubated, rolling, overnight at 37°C. Aliquots of these cultures were diluted 1:100 into 25 ml of LB containing antibiotics and IPTG (1 mM) in 125 ml DeLong flasks with Morton-style closures (Bellco Glass, Vineland, NJ), shaken at 37°C on an orbital platform shaker at 220--250 RPM. For the experiments shown in [Figure 4](#fig4){ref-type="fig"}, cultures were grown as described above, except that cells were initially back-diluted into a volume of 75 ml of media containing antibiotics and IPTG, mixed, and then 25 ml aliquots were transferred into each of two 125 ml flasks. One aliquot was used for each harvest time-point.

RNA isolation {#s4-4}
-------------

### Standard method ([Figure 1](#fig1){ref-type="fig"} and [Figure 3](#fig3){ref-type="fig"}) {#s4-4-1}

When cultures reached an OD~600~ between 0.8 and 1.0, 5 ml aliquots were harvested into 50 ml Oakridge tubes containing 15 ml of RNAlater solution (Life Technologies, Grand Island, NY) and mixed several times by inversion. Cell suspensions in RNAlater were incubated overnight at 4°C. Cells suspended in RNAlater were centrifuged at 17,000 × g for 20 min at 4°C; the supernatant was decanted and residual liquid carefully removed by pipetting. 1 ml of Tri-reagent (Molecular Research Center, Cincinnati, OH) was added to each tube and pellets were dispersed by vortexing. Cell suspensions in Tri-reagent were transferred to 1.7 ml low binding tubes (BioExcell; Worldwide Medical Products, Bristol, PA), incubated at 70°C for 10 min, centrifuged at 21,000 × g at 4°C for 10 min, and the supernatants were recovered into fresh tubes. 200 μl of chloroform was added to each tube and mixed by vigorous shaking for 15 s. Phases were separated by centrifugation at 21,000 × g at 4°C for 15 min. 500 μl of the upper, aqueous phase was recovered and transferred to a fresh tube to which 167 μl of 100% ethanol was added. Subsequent removal of RNA \>200 nt and recovery of RNA \<200 nt was performed using the mirVana microRNA Isolation kit (Life Technologies) according to the manufacturer\'s protocol. After elution from mirVana columns, eluents were concentrated by ethanol precipitation and resuspended directly into formamide loading dye (95% deionized formamide, 18 mM EDTA, and 0.025% SDS, xylene cyanol, bromophenol blue, amaranth).

### Rapid harvest method ([Figure 4](#fig4){ref-type="fig"}) for RNA stability measurements {#s4-4-2}

At T = 0 (log phase: OD~600~ ∼0.5 after 3hr growth; stationary phase: OD~600~ ∼2.5 after 21hr growth), a 2 ml aliquot was withdrawn from each culture and transferred to a 2 ml microcentrifuge tube and cells were immediately pelleted by centrifugation at 10,000 × g for 30 s at 37°C. Supernatants were decanted and pellets placed immediately onto dry ice. To facilitate rapid handling, the dry ice and microcentrifuge were placed adjacent to the platform shaker in the 37°C environmental room and the microcentrifuge was allowed to equilibrate to ambient temperature prior to use. After the T = 0 pellets were frozen, rifampicin (50 mg/ml in DMSO) was added to the remaining culture volume to a final concentration of 1 mg/ml. Rapid harvest was performed as described for the T = 0 fraction. The post-rifampicin time-points refer to when the cell pellets were placed on dry ice. Pellets were stored at −80°C until needed. Frozen cell pellets were resuspended directly into 200 μl of Tri-reagent, heated at 60°C for 10 min, cleared of debris by centrifugation at 21,000 × g at 4°C for 10 min, and the supernatants were recovered into fresh tubes. 40 μl of chloroform was added to each tube and mixed by vigorous shaking for 15 s. Phases were separated by centrifugation at 21,000 × g at 4°C for 15 min and 100 μl of the upper, aqueous phase was recovered. 33 μl of 100% ethanol was mixed with the recovered aqueous phase, the mixture was applied to a mirVana spin cartridge, and flowthrough collected after centrifugation at 10,000 × g at room temperature for 1 min. RNA was precipitated from the flowthrough by addition of 1 μl of 10 mg/ml glycogen and 240 μl of 100% ethanol followed by incubation at −20°C for 12--18 hr. Pellets were resuspended directly into formamide loading dye (see above).

### Method for isolation of RNAP-associated RNA ([Figure 3B](#fig3){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}) {#s4-4-3}

After cell cultures reached an OD~600~ of ∼0.5 (log phase) or ∼2.5 (stationary phase), a 10 ml volume of cell culture was centrifuged at 8000 × g for 5 min at ambient temperature. Supernatants were decanted and pellets frozen on dry ice. Cell lysis and RNA isolation were performed as described by [@bib53].

LNA probe labeling {#s4-5}
------------------

50 pmol of LNA probe (5′ agCaaAttAacCc 3′), where LNA bases are capitalized; Exiqon, Woburn, MA) was incubated in a 25 μl volume with 5 μl γ-^32^P-ATP (EasyTide; Perkin Elmer, Waltham, MA), 2.5 μl 10X T4 PNK buffer, 13.5 μl nuclease free water (Life Technologies), and 2 μl T4 PNK (NEB, Ipswich, MA) at 37°C for 1 hr followed by 95°C for 10 min. Labeled probe was separated from unincorporated radiolabeled nucleotide using a size-exclusion spin column (SigmaSpin; Sigma--Aldrich, St. Louis, MO).

Detection of pause RNAs and full-length RNAs in vivo by LNA hybridization {#s4-6}
-------------------------------------------------------------------------

RNAs generated in vivo were detected by hybridization as described in ([@bib39]; [@bib11]; [@bib8]) using a 5′ radiolabeled LNA probe. RNA was loaded onto 0.4 mm thick 20% denaturing polyacrylamide slab gels cast and equilibrated in 50 mM MOPS (pH 7 with NaOH), transferred to neutral nylon membrane (Whatman Nytran N; GE Healthcare Life Sciences, Piscataway, NJ) using a semi-dry electroblotting apparatus (Biorad, Hercules, CA) operating at 20V for 25 min using chilled 20 mM MOPS (pH 7 with NaOH) as conductive medium. RNA was crosslinked to the membrane using 157 mM *N*-(3-dimethylaminopropyl)-*N*′-ethylcarbodiimide hydrochloride (EDC) (Sigma--Aldrich) in 0.97% 1-methylimidazole (pH 8) (Alfa Aesar, Ward Hill, MA) (as described in [@bib39]) for 80 min at 55°C. Crosslinking solution was rinsed from the membrane by immersion in 20 mM MOPS (pH 7 with NaOH) at 25°C, the membrane was placed onto nylon hybridization mesh, the membrane-mesh stack was placed into a 70 × 150 mm hybridization bottle at 50°C and 50 ml of pre-hybridization solution (5× SSC, 5% SDS, 2× Denhardt\'s solution, 40 μg/ml sheared salmon sperm DNA solution \[Life Technologies\], 20 mM Na~2~HPO~4~ \[pH 7.2\] in diethylpyrocarbonate (DEPC) treated water) at 50°C was added. The hybridization bottle was rotated in a hybrization oven at 50°C for 30 min, the solution was decanted and replaced by a 50 ml portion of pre-warmed hybridization solution that had been thoroughly mixed with the entire volume of the radiolabeled LNA probe prepared above. The bottle was then returned to the 50°C oven for 16 hr. The membrane was washed twice for 10 min in non-stringent wash buffer (3× SSC, 5% SDS, 10× Denhardt\'s solution, 20 mM Na~2~HPO~4~ \[pH 7.2\] in DEPC treated water), twice for 30 min in non-stringent wash buffer, and once for 5 min in stringent wash buffer (1× SSC, 1% SDS, in DEPC treated water) before it was blotted dry, wrapped in plastic film, and radiolabeled bands were visualized by storage phosphor screen (GE Healthcare) and phosphorimagery (Storm 830 imager or Typhoon 9400 variable mode imager, GE Healthcare). All wash buffers were equilibrated to 55°C prior to use. Hybridization oven was operated at 50°C throughout.

Protein isolation for immunoblotting {#s4-7}
------------------------------------

With the exception of [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}, protein isolation for immunoblotting was performed as follows. 1 ml of cell suspensions was pelleted by centrifugation at 10,000 × g for 2 min at ambient temperature, supernatants were carefully removed by vacuum aspiration and pellets were immediately frozen on dry ice before being stored at −80°C. To extract soluble protein, cell pellets were thawed on ice for ∼30 s and resuspended by pipetting in lysis solution normalized to 50 μl per 1 ml of OD~600~ = 0.6. Lysis solution consisted of 1 ml B-PER reagent (Thermo Scientific Pierce, Rockland, IL), 1/4 protease inhibitor tablet (Comlete-mini \[EDTA-free\]; Roche, Indianapolis, IN), 2 μl 0.5M EDTA (pH 8), 2 μl lysozyme (50 mg/ml), 120 μl TurboDNase (Life Technologies), and 200 μl 10× TurboDNase buffer. Lysis mixture was incubated 10 min on ice. Lysates were centrifuged at 21,000 × g for 10 min at 4°C to pellet insoluble material. 40 μl of clarified supernatant was then mixed with an equal volume of 2× loading buffer prepared by mixing 500 μl 4× NuPAGE LDS sample buffer (Life Technologies), 50 μl β-mercaptoethanol and 450 μl water. Samples were heated at 70°C for 2 min and centrifuged at 21,000 × g for 2 min at ambient temperature prior to electrophoresis.

For the experiment of [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}, total cellular protein was isolated as follows. Cell pellets, obtained and stored as described above, were resuspended directly into 50 μl per 1 ml of OD~600~ = 0.6 of 1× Laemmli SDS sample buffer (pH 7.4) and heated 90°C for 5 min. Debris was pelleted by centrifugation at 21,000 × g for 5 min and the supernatants were transferred to fresh tubes and analyzed by gel electrophoresis.

Immunoblotting {#s4-8}
--------------

With the exception of [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}, immunoblots were performed as follows. 10 μl of each soluble protein sample was loaded onto a 4--12% gradient NuPAGE Novex Bis-Tris precast gel (Life Technologies) and run in 1X NuPAGE MOPS SDS running buffer until the dye front exited the gel. The gel cassette was then opened and the gel was equilibrated into transfer buffer (192 mM glycine, 25 mM Tris, 10% methanol) for 5--10 min. PVDF membrane (Immobilon-FL; EMD-Millpore) was wetted in 100% methanol and equilibrated into transfer buffer prior to transfer-stack assembly. Semi-dry electro transfer was performed using a Trans-Blot SD apparatus (Bio-Rad) operating at 10V for 1 hr. After transfer, membranes were placed into blocking solution (5% non-fat dry milk in 1× PBS) and gently agitated at ambient temperature for 30 min. Blocking solution was decanted and replaced with 10 ml of a 1:5000 dilution of affinity purified mouse monoclonal antibody recognizing σ^70^ (clone 2G10; Neoclone, Madison, WI) or σ^28^ (clone 1RF18; Neoclone) in blocking solution and gently agitated for 1 hr as above. The primary antibody solution was decanted and the membrane washed quickly in 10 sequential portions of blocking solution containing 0.1% TWEEN-20. Goat anti-mouse IRDye 680LT secondary antibody (Li-Cor Biosciences, Lincoln, NE) was diluted 1:20,000 into 20 ml of blocking solution containing 0.1% TWEEN-20 and 0.02% SDS and 10 ml was added to the membrane which was then incubated and washed as above except that the membrane was kept in the dark during incubation and several quick washes in 1× PBS were performed to remove residual milk prior to imaging. Data was acquired using an Odyssey Classic infra-red imager (Li-Cor Biosciences). For the blot shown in [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}, total cellular protein was electrophoresed and transferred as above except that nitrocellulose membrane (Protran NC, GE Healthcare) was used. Detection of protein was performed using a 1:20,000 dilution of Goat anti-Mouse HRP conjugated secondary antibody, ECL reagents (SuperSignal West, Pierce) and a ChemiDoc XRS + instrument (Bio-Rad). Quantification was performed using ImageLab software.

Proteins {#s4-9}
--------

His-tagged σ^70^ and σ^28^ were purified from BL21(DE3) cells transformed with pLHN12-His and pET15b-His-fliA, respectively, as described previously ([@bib41]). *E. coli* core RNAP was purchased from Epicentre (Madison, WI). Holoenzymes were formed by mixing core RNAP and a twofold molar excess of σ^70^ or a fivefold molar excess of σ^28^ in transcription buffer (20 mM Tris--HCl pH 8.0, 0.1 mM EDTA, 100 mM K-acetate, 100 μg/ml BSA, 10 mM DTT, 5% glycerol, and 0.025% Tween-20) and incubating at 37°C for 10 min.

In vitro transcription assays {#s4-10}
-----------------------------

Linear transcription templates were synthesized by PCR using plasmid DNAs (pFW11tet-Ptar\_+19, pFW11tet-Ptar_mut+19 or pFW11tet-mutPR′\_+19) as template and oligonucleotides that anneal to sequences ∼100 bp upstream of the +1 transcription start site (5′ CCTATAAAAATAGGCGTATCACGAG 3′) and ∼135 bp downstream of the transcription termination site ( 5′ CAGGGTTTTCCCAGTCACGACGTTG 3′). 20 nM PCR template was mixed with 15 nM of the appropriate RNAP holoenzyme or RNAP core enzyme in transcription buffer containing 200 μM ATP, 200 μM GTP, 200 μM CTP, 25 μM UTP (supplemented with 0.5 μCi/μL \[α-^32^P\]-UTP; Perkin Elmer), and 0.5 units/μl Murine RNase Inhibitor (NEB) for 5 min at 37°C to form open complexes. A single round of transcription was initiated by adding MgCl~2~ (4 mM final concentration) and rifampicin (10 µg/ml final concentration), as described previously ([@bib12]; [@bib51]; [@bib18]). When present, excess σ^70^ was added together with the MgCl~2~ and rifampicin to a final concentration of 1 μM. Aliquots of the reaction were removed at 1, 6, and 18 min and mixed with 1.2 × stop buffer (600 mM Tris--HCl pH 8.0, 12 mM EDTA, and 100 μg/mL Ambion Yeast RNA \[Life Technologies\]). Samples were extracted with acid phenol:chloroform and RNA transcripts were recovered by ethanol precipitation and resuspended in gel loading buffer (95% formamide,18 mM EDTA, 0.025% SDS, 0.025% xylene cyanol, 0.025% bromophenol blue, 0.025% amaranth). Samples were heated at 95°C for 5 min, cooled to room temperature, and run on 12% TBE-Urea polyacrylamide gels (UreaGel system; National Diagnostics, Atlanta, GA). Autoradiography of gels was performed using storage phosphor screens and a Typhoon 9400 variable mode imager (GE Healthcare) and quantified using ImageQuant software.
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\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for choosing to send your work entitled "The primary σ factor in *Escherichia coli* can access the transcription elongation complex from solution in vivo" for consideration at *eLife*. Your full submission has been evaluated by Richard Losick (Senior Editor), a member of the Board of Reviewing Editors, and three peer reviewers, one of whom, Lucia Rothman-Denes, has agreed to reveal her identity.

We regret to inform you that your work will not be considered further for publication in *eLife*. The decision was reached after discussions between the reviewers.

As you can see from the individual reviews, two of the reviewers were reasonably enthusiastic about your study but one felt the paper fell short of the stated aims. All three reviewers were concerned about the relevance of the σ^70^ overproduction. If this critique can be addressed by additional experiments that identify physiological conditions where σ^70^ levels increase dramatically or examine the effects of an alternative σ factor on transcription elongation initiated from a σ^70^-dependent promoter you might consider sending the manuscript back to *eLife*.

Reviewer \#1:

This brief paper is a "proof-of-concept" study that establishes the potential for loading of σ^70^ in *trans* at sites downstream of transcription start sites to regulate transcript elongation in vivo. The authors demonstrate that σ^70^ loads in *trans* at a −10-like element downstream of the λP~R~ promoter in vivo, that it increases pausing at this site, that σ^70^ can load downstream even when the transcript is initiated at a promoter directed by an alternative holoenzyme (Es28; thus establishing that σ^70^ really is loading in trans), that the level of the resulting pause increases in a σ^70^ concentration-dependent manner (further evidence that the effect is exerted in trans), and that the total fraction of transcripts that pause is additive with the effect in *cis* of a σ binding site in the initial transcribed region. The effects are small at natural concentrations of σ^70^ but quite strong when σ^70^ is overproduced. The experiments are well-designed, the results are clear, and the description is precise. These are important findings, building on a proposal from the Landick lab about 10 years ago from experiments with a σ factor fused to core RNAP. The potential that specific operons are regulated by either free σ^70^ or other σ factors at entry sites within the coding regions of operons is enticing. A few ideas for improvements in presentation are listed below, but otherwise the paper is ready to go.

1\) It is not clear to me why [Figure 5](#fig5){ref-type="fig"} is presented after the cartoon/summary slide in the Discussion. It seems like it would make more sense to present [Figure 5](#fig5){ref-type="fig"} as [Figure 4](#fig4){ref-type="fig"}, just after [Figure 3](#fig3){ref-type="fig"}, in the Results section, before the summary slide in the Discussion section. The experiment pictured in [Figure 5](#fig5){ref-type="fig"} is, after all, an important Result. Its presentation in the Discussion makes it seem like an afterthought.

2\) Although the technical quality of the paper is high, the importance of σ binding in *trans* to transcription in native operons at levels of σ that exist in nature awaits further studies. The amount of pausing induced by native levels of σ^70^ appears to be fairly low, and there is no nutritional/environmental condition to my knowledge when σ^70^ is overproduced. This should be acknowledged in a more forthright manner, but some potential conditions when such a phenomenon might influence transcription might be expanded on. For example, most of the alternative σ factors are induced naturally, some to quite high levels, and one could imagine that binding sites for these σs at strategic positions in the transcribed region might transiently influence elongation in *trans*.

3\) Another direction for the future that might be introduced in the Discussion to add to the impact of the present study would be a genome-wide analysis of the transcriptome following induction of one or more σs. These might turn up candidates for further exploration of in *trans* effects of σ binding at natural levels of σ.

Reviewer \#2:

The Hochschild and Nickels labs have previously shown that the initial-transcribed sequences, sequences that lead to pausing of RNA polymerase due to interactions of σ^70^ region 2 with −10 -like sequences, affect the content of σ^70^ in transcription elongation complexes (TECs) in vivo. In addition, they showed that increases in the concentration of σ^70^ increased the efficiency of pausing in vitro.

In this manuscript, they test the in vivo effect of changes in the intracellular concentration of σ^70^ on the proportion of TECs that contain σ^70^. The results presented indicate that in vivo increases in the concentration of σ^70^ lead to increases of its content in TECs whether the TECs originate from σ^70^ or σ^28^-dependent promoters. The results provide further evidence to the growing appreciation of the role of σ factors as a component of the elongation machinery with its implications such as: 1) the ability to affect directly the behavior of the elongation complex through pausing with possible consequences for regulating translation, 2) the ability to compete with or recruit other elongation factors, or 3) trans-regulation of elongation complexes originating from alternative σ factor-dependent promoters.

Requiring clarification:

The experiment in [Figure 1](#fig1){ref-type="fig"} is performed at a 6--7 fold increase in the concentration of σ^70^ over wild-type conditions. Under what experimental conditions is that increase expected in the absence of over-production? Or how sensitive is the response to increases in the concentration of σ^70^.

Reviewer \#3:

The manuscript by Goldman et al. aims at demonstrating the action of the *E. coli* primary transcription initiation σ factor, σ^70^, upon transcript elongation, both in vitro and in vivo. Unfortunately, the manuscript under review falls far short of its stated aim and cannot be recommended for publication in *eLife* in its current form.

It is a generally accepted view in the transcription field that shortly after synthesis of 30--50 nt-long RNA by a bacterial RNA polymerase, the initiation/σ factor is released from the transcription complex, likely in competition with nascent RNA and/or elongation factors, such as NusG. Apart from the promoter-proximal σ^70^-dependent pausing, no convincing data exists pointing to the larger role of initiation factor during the elongation phase of transcription. Goldman et al. do not go beyond this already established fact (by focusing on promoter-proximal pausing), nor do they add any new information or nuance to the subject matter. In fact the experiments reported in the manuscript are fairly limited in scope whereas their interpretations are rather over-reaching.

All the experiments reported by Goldman et al. focus on promoter-proximal transcription events, in fact the entire length of the templates used both in vitro and in vivo is ∼116 bp (from the start site to terminator). These offer no new insights into the σ^70^-dependent pausing per se, while the trans-loading onto early elongation complexes formed by σ28-containing holoenzymes is a fairly trivial observation. The significance of the manuscript\'s "findings" is dramatically overstated: e.g. the "control" of elongation by σ^70^ in vitro is not quantified in terms of elongation rate, pausing efficiency or pause half-life, instead the reader is presented with a (phosphor)image ([Figure 2](#fig2){ref-type="fig"}) s/he can only eyeball. Based on such eyeballing this reviewer concludes that the σ^70^ effects on elongation are minimal (judging by the apparent "amount" of full-length product) and limited to the induction of promoter-proximal arrest or termination in a small fraction of complexes. These complexes are labeled as "pause" on [Figure 2](#fig2){ref-type="fig"} without any merit: there is no apparent time-decay (escape from the pause site), and no discernable escape from these "pauses" for up to 18 min (lanes 6 and 18). Moreover, it was not determined whether or not the shorter transcripts were still associated with RNA polymerase (which would distinguish paused/arrested complexes from terminated ones). As such, all that can be asserted from these experiments is the changes in RNA length. The same applies to the in vivo experiments reported by Goldman et al. Physical loading of σ^70^ onto elongation complexes has not been demonstrated either in vivo or in vitro which in turn means that Goldman et al. should limit their conclusions to a simple correlation between the concentration of σ^70^ and the abundance of the short transcripts produced from a handful of artificial templates.

The technical aspect of the work reported by Goldman et al. is confusing. This is especially evident in the description of their in vitro experiments: the authors claim to initiate transcription in vitro by adding together MgCl2 (which supplies catalytic Mg^2+^) and rifampicin (which inhibits transcription initiation by restricting nascent RNA synthesis to the first 3--4 nt) to the pre-formed open complexes. In single-round transcription assays, rifampicin is routinely added after the elongation complex is stalled (by selective NTP deprivation) in proximity to the promoter (and is no longer sensitive to it) to prevent re-initiation. As described by Goldman et al. the single-round assay would be a no-round one and the transcripts depicted in [Figure 2](#fig2){ref-type="fig"} could not have been obtained as described in the Materials and methods.

Furthermore, in order to make such assays quantitative the radioactively labeled nucleotide is usually supplied at the initiation stage and is incorporated into a defined length of RNA (essentially an end-labeling). This nucleotide is later removed (e.g. by gel-filtration) or diluted to negligible levels by the excess of the unlabeled one in the chase/extension mix. This way the amount of radioactivity in RNA is practically length-independent, enabling quantitative kinetic analysis of pausing, termination, etc. In contrast, in experiments described by Goldman et al. both labeled and un-labeled UTP are present in the reaction mix together from the start and no measure is mentioned that was taken to remove/dilute P32-labeled one. This makes the amount of radioactivity in the transcript dependent on its length and sequence (more radioactivity is incorporated as the transcript grows) rendering any quantitative interpretation of the data impractical.

The conclusions Goldman et al. derive from their in vivo experiments call for greater scope and technical sophistication of experimentation than the ones employed (i.e. monitoring the levels of transcripts produced from 2 short artificial templates by LNA hybridization and of 2 proteins by Western blotting). High-throughput/deep sequencing and mass-spectrometry allow for much more rigorous and quantitative monitoring of the proposed control σ^70^ exerts over various stages of transcription in vivo (and incidentally of the impact its overexpression would have on the proteome outside its own concentration). These methods are presently accessible and affordable enough to make the approach chosen by Goldman et al. seem somewhat myopic in scope, and archaic in design.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for submitting your work entitled "The primary σ factor in *Escherichia coli* can access the transcription elongation complex from solution in vivo" for peer review at *eLife*. Your submission has been favorably evaluated by Richard Losick (Senior Editor), a Reviewing Editor, and three reviewers, one of whom, Lucia Rothman-Denes, has agreed to reveal her identity.

The reviewers discussed the reviews with one another and all felt the manuscript has significantly improved over the first submission. The Reviewing Editor has drafted this decision to help you prepare a revised submission.

Previous in vitro experiments showed that σ^70^ increases the efficiency of pausing at −10-like elements when supplied from solution (trans-loading). This study demonstrates that trans-loading occurs in vivo; σ^70^ can associate with a transcription complex initiated from an upstream σ^28^-dependent promoter and affect pausing of the complex, particularly in stationary phase.

Essential revisions:

1\) The reviewers were not able to reach a consensus on whether genome-wide ChIP-seq and transcriptome-wide RNASeq studies were needed to address the physiological significance of trans-loading. The authors should discuss whether trans-loading is just an accidental process or plays a meaningful role in the cell and what approaches will be needed to address the biological significance of trans-loading in the future.

2\) In experiments designed to compare the level of transcripts originating from plasmids in exponentially growing cells with those in stationary phase no effort was made to ascertain whether the plasmid levels (copy numbers) remained equal at the two growth stages (most likely were not). The authors should determine copy number under the two conditions or explain why this is not a valid concern.

3\) [Figure 2A](#fig2){ref-type="fig"}: Sequences upstream of +1 should be added up to the −35 element, since these determine the appearance of the (\*) transcript.

4\) [Figure 4A](#fig4){ref-type="fig"}. Figure heading needs to be corrected: top lane is template; second lane is growth phase.

10.7554/eLife.10514.011

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

We thank the reviewers for their comments, which we respond to in detail below. We believe that our revised manuscript addresses the main overall critique of our original manuscript -- namely that we had not identified a physiological condition under which σ^70^ *trans* loading could be expected to have a significant effect on transcription in the cell. We now show that the effect of σ^70^ *trans* loading on transcription pausing becomes highly significant in the absence of ectopically produced σ^70^ when the cells are in stationary phase. In particular, we observe an −10-fold increase in the abundance of the pause species in stationary-phase cells as compared to exponential-phase cells (see [Figure 4](#fig4){ref-type="fig"} of the revised manuscript). The use of a σ^28^-dependent transcription unit to demonstrate this growth phase- dependent effect of σ^70^ on transcription pausing establishes unequivocally that the effect is due to *trans*-loaded σ^70^ and not σ^70^ that has been retained following the transition from initiation to elongation. Additionally, in response to reviewer \#3, we have shown that the short transcripts that we identify as pause RNAs are in fact RNAP-associated, confirming their identify as pause species.

*\[...\] As you can see from the individual reviews, two of the reviewers were reasonably enthusiastic about your study but one felt the paper fell short of the stated aims. All three reviewers were concerned about the relevance of the σ*^*70*^ *overproduction. If this critique can be addressed by additional experiments that identify physiological conditions where σ*^*70*^ *levels increase dramatically or examine the effects of an alternative σ factor on transcription elongation initiated from a σ*^*70*^*-dependent promoter you might consider sending the manuscript back to* eLife*.*

Reviewer \#1:

*1) It is not clear to me why* [*Figure 5*](#fig5){ref-type="fig"} *is presented after the cartoon/summary slide in the Discussion. It seems like it would make more sense to present* [*Figure 5*](#fig5){ref-type="fig"} *as* [*Figure 4*](#fig4){ref-type="fig"}*, just after* [*Figure 3*](#fig3){ref-type="fig"}*, in the Results section, before the summary slide in the Discussion section. The experiment pictured in* [*Figure 5*](#fig5){ref-type="fig"} *is, after all, an important Result. Its presentation in the Discussion makes it seem like an afterthought*.

We agree that this Figure was awkwardly placed. We now present this result in [Figure 1](#fig1){ref-type="fig"} (as panel B), after showing the effect of σ^70^ overproduction on the template that bears the single transcribed-region pause element.

*2) Although the technical quality of the paper is high, the importance of σ binding in* trans *to transcription in native operons at levels of σ that exist in nature awaits further studies. The amount of pausing induced by native levels of σ*^*70*^ *appears to be fairly low, and there is no nutritional/environmental condition to my knowledge when σ*^*70*^ *is overproduced. This should be acknowledged in a more forthright manner, but some potential conditions when such a phenomenon might influence transcription might be expanded on. For example, most of the alternative σ factors are induced naturally, some to quite high levels, and one could imagine that binding sites for these σs at strategic positions in the transcribed region might transiently influence elongation in trans*.

In our revised manuscript, we describe a condition that leads to a high degree of pausing in the absence of ectopically produced σ^70^. In particular, we now show that the effect of σ^70^ *trans* loading on transcription pausing manifests a dramatic growth phase dependence. Thus, we observe an ∼10-fold increase in the abundance of the pause species in stationary-phase cells as compared to exponential-phase cells (see [Figure 4](#fig4){ref-type="fig"} of the revised manuscript). The amount of pausing we detect in stationary phase cells containing chromosomally encoded σ^70^ only is greater than that detected during exponential phase with σ^70^ overproduction. A rifampicin time-course experiment suggests that the observed increase in the abundance of the pause species is due, at least in part, to a decrease in pause half-life ([Figure 4B](#fig4){ref-type="fig"}). Although we did not detect an increase in the total cellular concentration of σ^70^ in stationary phase, we cannot exclude the possibility that the amount of free σ^70^ available to bind the TEC varies with growth phase.

*3) Another direction for the future that might be introduced in the Discussion to add to the impact of the present study would be a genome-wide analysis of the transcriptome following induction of one or more σs. These might turn up candidates for further exploration of in* trans *effects of σ binding at natural levels of σ*.

We agree with the reviewer and intend to use NET-seq (with an epitope-tagged version of σ^70^) to perform such genome-wide analyses.

Reviewer \#2:

*Requiring clarification*:

*The experiment in* [*Figure 1*](#fig1){ref-type="fig"} *is performed at a 6--7 fold increase in the concentration of σ*^*70*^ *over wild-type conditions. Under what experimental conditions is that increase expected in the absence of over-production? Or how sensitive is the response to increases in the concentration of σ*^*70*^.

See response to reviewer \#1, point 2, describing our new data. With regard to the sensitivity of the response, we note that in the experiment of [Figure 3](#fig3){ref-type="fig"} (with the P*tar* template) a comparable increase in σ^70^-dependent pausing is observed with only an ∼3-fold increase in the concentration of σ^70^.

Reviewer \#3:

*\[...\] It is a generally accepted view in the transcription field that shortly after synthesis of 30-50 nt-long RNA by a bacterial RNA polymerase, the initiation/σ factor is released from the transcription complex, likely in competition with nascent RNA and/or elongation factors, such as NusG. Apart from the promoter-proximal σ*^*70*^*-dependent pausing, no convincing data exists pointing to the larger role of initiation factor during the elongation phase of transcription. Goldman et al. do not go beyond this already established fact (by focusing on promoter-proximal pausing), nor do they add any new information or nuance to the subject matter. In fact the experiments reported in the manuscript are fairly limited in scope whereas their interpretations are rather over-reaching*.

Although σ^70^-dependent pausing has indeed been well established, our finding that such pausing can occur in vivo due to *trans* loaded σ^70^ is new. We believe that our revised manuscript provides strong evidence for physiological relevance with the new demonstration that the abundance of paused species due to *trans* loaded σ^70^ is dramatically increased during stationary phase.

*All the experiments reported by Goldman et al. focus on promoter-proximal transcription events, in fact the entire length of the templates used both in vitro and in vivo is ∼ 116 bp (from the start site to terminator). These offer no new insights into the σ*^*70*^*-dependent pausing per se, while the trans-loading onto early elongation complexes formed by σ*^*28*^*-containing holoenzymes is a fairly trivial observation*.

Our experimental system enables the detection of pausing events that occur relatively close to the promoter. But as these events are unambiguously occurring during the elongation phase of transcription, we do not believe their significance is diminished by their promoter-proximal location. We note that the 5'- untranslated region is the locus of many well characterized examples of post-initiation transcription regulation, and that early elongation pausing is emerging as a theme in both prokaryotic and eukaryotic transcription. With also wish to emphasize that the use of a σ^28^-dependent transcription unit for our experiments enables us to distinguish unequivocally between pausing due to retained σ^70^ and pausing due to *trans* loaded σ^70^. And, as noted above, the growth phase dependence of pausing due to *trans* loaded σ^70^ that we now report suggests that such pausing has the potential to influence the entire transcriptome.

*The significance of the manuscript\'s "findings" is dramatically overstated: e.g. the "control" of elongation by σ*^*70*^ *in vitro is not quantified in terms of elongation rate, pausing efficiency or pause half-life, instead the reader is presented with a (phosphor)image (*[*Figure 2*](#fig2){ref-type="fig"}*) s/he can only eyeball. Based on such eyeballing this reviewer concludes that the σ*^*70*^ *effects on elongation are minimal (judging by the apparent "amount" of full-length product) and limited to the induction of promoter-proximal arrest or termination in a small fraction of complexes. These complexes are labeled as "pause" on* [*Figure 2*](#fig2){ref-type="fig"} *without any merit: there is no apparent time-decay (escape from the pause site), and no discernable escape from these "pauses" for up to 18 min (lanes 6 and 18)*.

We wish to clarify that the purpose of our study is to investigate whether or not σ^70^ *trans* loading occurs in vivo, and what it's potential impact might be. As cited in the manuscript, σ^70^ *trans* loading in vitro has been demonstrated previously. The point of the in vitro transcription experiments shown in [Figure 2](#fig2){ref-type="fig"} is simply to establish a correspondence between the pause species that arise when transcription initiates from ^λP^~R\'~ (as reported previously) and those that arise when transcription initiates from a σ^28^-dependent promoter. Our previous study with the ^λP^~R\'~ template ([@bib8]) established the identity of the ∼35-nt RNAs as σ^70^-dependent pause species based on 4 characteristics, including their sensitivity to the transcript cleavage factor GreB and their sensitivity to a mutation in σ^70^ that causes a defect in σ^70^-dependent pausing. In the context of the current study, we did not think it appropriate to repeat these tests. In the revised manuscript, we now clarify that the transcription reactions were performed in the absence of GreA and GreB, which accounts for the long-lived pause species (see legend to [Figure 2](#fig2){ref-type="fig"}); in Deighan et al., we show that the pause species chase very quickly when GreB is added to the reactions.

*Moreover, it was not determined whether or not the shorter transcripts were still associated with RNA polymerase (which would distinguish paused/arrested complexes from terminated ones). As such, all that can be asserted from these experiments is the changes in RNA length. The same applies to the in vivo experiments reported by Goldman et al. Physical loading of σ*^*70*^ *onto elongation complexes has not been demonstrated either in vivo or in vitro which in turn means that Goldman et al. should limit their conclusions to a simple correlation between the concentration of σ*^*70*^ *and the abundance of the short transcripts produced from a handful of artificial templates*.

In our revised manuscript, we have addressed the reviewer's concern about whether or not the short (∼35-nt) RNA species observed in vivo actually represent pause RNAs. Specifically, we have shown that these species are RNAP-associated by performing immunoprecipitation experiments using a strain that encodes the RNAP β' subunit with a C-terminal 3xFLAG tag (see new panel B of [Figure 3](#fig3){ref-type="fig"} and [Figure 4--figure supplement 1A](#fig4s1){ref-type="fig"}).

*The technical aspect of the work reported by Goldman et al. is confusing. This is especially evident in the description of their in vitro experiments: the authors claim to initiate transcription in vitro by adding together MgCl2 (which supplies catalytic Mg*^*2+*^*) and rifampicin (which inhibits transcription initiation by restricting nascent RNA synthesis to the first 3--4 nt) to the pre-formed open complexes. In single-round transcription assays, rifampicin is routinely added after the elongation complex is stalled (by selective NTP deprivation) in proximity to the promoter (and is no longer sensitive to it) to prevent re-initiation. As described by Goldman et al. the single-round assay would be a no-round one and the transcripts depicted in* [*Figure 2*](#fig2){ref-type="fig"} *could not have been obtained as described in the Materials and methods*.

We neglected to specify in the original manuscript that this is a well-established procedure for initiating single-round transcription, which is effective because most of the transcription complexes escape into productive elongation before rifampicin reaches its binding site on RNAP. We now clarify this point by citing several prior studies that use this method to initiate single-round transcription (including two of a large number of papers from the Roberts lab over a 30-year period).

*Furthermore, in order to make such assays quantitative the radioactively labeled nucleotide is usually supplied at the initiation stage and is incorporated into a defined length of RNA (essentially an end-labeling). This nucleotide is later removed (e.g. by gel-filtration) or diluted to negligible levels by the excess of the unlabeled one in the chase/extension mix. This way the amount of radioactivity in RNA is practically length-independent, enabling quantitative kinetic analysis of pausing, termination, etc. In contrast, in experiments described by Goldman et al. both labeled and un-labeled UTP are present in the reaction mix together from the start and no measure is mentioned that was taken to remove/dilute P32-labeled one. This makes the amount of radioactivity in the transcript dependent on its length and sequence (more radioactivity is incorporated as the transcript grows) rendering any quantitative interpretation of the data impractical*.

As we hope we have clarified, we are not attempting to make any quantitative argument about the in vitro data. The focus of our study is the question of what occurs in vivo.

*The conclusions Goldman et al. derive from their in vivo experiments call for greater scope and technical sophistication of experimentation than the ones employed (i.e. monitoring the levels of transcripts produced from 2 short artificial templates by LNA hybridization and of 2 proteins by Western blotting). High-throughput/deep sequencing and mass-spectrometry allow for much more rigorous and quantitative monitoring of the proposed control σ*^*70*^ *exerts over various stages of transcription in vivo (and incidentally of the impact its overexpression would have on the proteome outside its own concentration). These methods are presently accessible and affordable enough to make the approach chosen by Goldman et al. seem somewhat myopic in scope, and archaic in design*.

We believe that a genome-wide analysis of the effects of σ^70^ *trans* loading is beyond the scope of the current study, though we certainly agree that such experiments will be revealing. We do not agree with the reviewer's assessment of our approaches in the study, which we believe are well suited to address the questions we sought to investigate.

\[Editors\' note: the author responses to the re-review follow.\]

*Essential revisions*:

*1) The reviewers were not able to reach a consensus on whether genome-wide ChIP-seq and transcriptome-wide RNASeq studies were needed to address the physiological significance of trans-loading. The authors should discuss whether trans-loading is just an accidental process or plays a meaningful role in the cell and what approaches will be needed to address the biological significance of trans-loading in the future*.

We have added a sentence to the last paragraph of the Discussion in which we specify what approaches will be useful in the future to identify transcription units that manifest pausing that is attributable to *trans*-loaded σ^70^.

*2) In experiments designed to compare the level of transcripts originating from plasmids in exponentially growing cells with those in stationary phase no effort was made to ascertain whether the plasmid levels (copy numbers) remained equal at the two growth stages (most likely were not). The authors should determine copy number under the two conditions or explain why this is not a valid concern*.

We agree that plasmid copy number might differ between exponentially growing cells and stationary phase cells. However, we do not believe any such difference would invalidate our conclusion that the extent of pausing due to *trans*-loaded σ^70^ varies with growth phase. Specifically, we show that pause half-life increases significantly during stationary phase, an effect that could not be explained by changes in plasmid copy number. We conclude in the manuscript that the observed effect of growth phase on the extent of pausing is due "at least in part" to an increase in the half-life of the pause (Results, last sentence and Discussion, subsection "Dual pathways for σ^70^ to associate with the TEC in vivo", second paragraph).

*3)* [*Figure 2*A](#fig2){ref-type="fig"}*: Sequences upstream of +1 should be added up to the -35 element, since these determine the appearance of the (\*) transcript*.

We have included the sequences upstream of +1 for each promoter in the Materials and methods (and cited this in the legend to [Figure 2](#fig2){ref-type="fig"}). We note that the appearance of the (\*) transcript can be explained by the fact that the pause element is an extended −10 element (TGNTATAAT).

*4)* [*Figure 4*A](#fig4){ref-type="fig"}*. Figure heading needs to be corrected: top lane is template; second lane is growth phase*.

The figure heading has been corrected.

[^1]: These authors contributed equally to this work.
